Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis

被引：1

作者：

Magnuson, W. J. ^{[1
]}

Amini, A. ^{[2
]}

Patil, T. ^{[3
]}

Kavanagh, B. D. ^{[2
]}

Camidge, D. R. ^{[4
]}

Braunstein, S. E. ^{[5
]}

Boreta, L. ^{[5
]}

Attia, A. ^{[6
]}

Rana, N. ^{[6
]}

Contessa, J. N. ^{[1
]}

Gettinger, S. N. ^{[7
]}

Lester-Coll, N. H. ^{[1
]}

Yu, J. B. ^{[8
]}

Chiang, V. L. ^{[9
]}

机构：

[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA

[2] Univ Colorado Denver, Dept Radiat Oncol, Aurora, CO USA

[3] Univ Colorado, Dept Internal Med, Denver, CO 80202 USA

[4] Univ Colorado, Dept Med Oncol, Denver, CO 80202 USA

[5] Univ Calif San Francisco, San Francisco, CA 94143 USA

[6] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA

[7] Yale Univ, Dept Med Oncol, New Haven, CT USA

[8] Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA

[9] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期

关键词：

D O I：

10.1016/j.ijrobp.2016.06.149

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

128

引用

页码：S57 / S58

页数：2

共 50 条

[41] Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients
Hanjing Yin
Wenxiao Jia
Jinming Yu
Hui Zhu
BMC Cancer, 24
[42] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
Otsuka, Kyoko
Hata, Akito
Takeshita, Jumpei
Okuda, Chiyuki
Kaji, Reiko
Masago, Katsuhiro
Fujita, Shiro
Katakami, Nobuyuki
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 835 - 841
[43] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
Kyoko Otsuka
Akito Hata
Jumpei Takeshita
Chiyuki Okuda
Reiko Kaji
Katsuhiro Masago
Shiro Fujita
Nobuyuki Katakami
Cancer Chemotherapy and Pharmacology, 2015, 76 : 835 - 841
[44] Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis
Yoshimura, Akihiro
Yamada, Tadaaki
Tsuji, Taisuke
Hamashima, Ryosuke
Shiotsu, Shinsuke
Yuba, Tatsuya
Takumi, Chieko
Uchino, Junji
Hiraoka, Noriya
Takayama, Koichi
THORACIC CANCER, 2019, 10 (03) : 557 - 563
[45] Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer
Wiest, Nathaniel
Majeed, Umair
Seegobin, Karan
Zhao, Yujie
Lou, Yanyan
Manochakian, Rami
FRONTIERS IN ONCOLOGY, 2021, 11
[46] Radiotherapy Plus EGFR TKIs for Brain Metastasis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Analysis of a Single Institution
Zhang, Jiexia
Shi, Xiaoshun
Cai, Di
Li, Xiaoxiang
Wu, Zhuolin
Liang, Ying
Qin, Yinyin
Zhou, Chengzhi
He, Jianxing
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S263 - S263
[47] Radiation As a Local Ablative Therapy Option for Oligoprogressive EGFR-Mutant Non-Small Cell Lung Cancer after Treatment with Osimertinib
Kesarwala, A. H.
Kim, C.
Jones, J. C.
Kaushal, A.
Roper, N.
Hoang, C. D.
Szabo, E.
Connolly, M.
Padiernos, E.
Cultraro, C.
Waris, M.
Gao, S.
Steinberg, S. M.
Khan, J.
Rajan, A.
Guha, U.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E467 - E468
[48] EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: A systematic review and meta-analysis
Soon, Yu Yang
Leong, Cheng Nang
Koh, Wee Yao
Tham, Ivan Weng Keong
RADIOTHERAPY AND ONCOLOGY, 2015, 114 (02) : 167 - 172
[49] Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer
Soo, Ross A.
Kim, Hye Ryun
Asuncion, Bernadette Reyna
Fazreen, Zul
Omar, Mohamed Feroz Mohd
Herrera, Maria Cynthia
Lim, Joey Sze Yun
Sia, Grace
Soong, Richie
Cho, Byoung-Chul
LUNG CANCER, 2017, 105 : 17 - 22
[50] ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
Ortega-Franco, Ana
Rafee, Shereen
ONCOLOGY AND THERAPY, 2022, 10 (01) : 13 - 22

← 1 2 3 4 5 →